Welcome to the ValueWiki Nymox Pharmaceutical Corporation (NYMX) article! Register for free or click the "edit" link to contribute!

Nymox Pharmaceutical Corporation (NYMX)

This summary section needs content! Click Here to begin writing.

Have a question about Nymox Pharmaceutical Corporation? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

11/19/08 10:11 am	Nymox Announces NEXUS-1 and NEXUS-2 Phase 3 Trials for NX-1207 Investigational Drug for BPH (Business Wire)
11/14/08 10:11 am	Nymox Reports Third Quarter 2008 Financial Results (Business Wire)
11/12/08 10:11 am	Nymox Reports Positive New Results in 59 Week Study of Drug for Enlarged Prostate (Business Wire)
10/30/08 11:10 am	Nymox NX-1207 Data Presented Today at American Urological Association Meeting in Monterey (Business Wire)
10/29/08 9:10 am	Powerful New Evidence Shows Statin Drugs Reduce Risk of Alzheimer's Disease (Business Wire)
10/28/08 11:10 am	Recent Clinical Trial data for Nymox NX-1207 Drug to Be Presented at American Urological Association Meeting in Monterey on Thursday (Business Wire)
10/22/08 10:10 am	Nymox Nears Completion of New One Year U.S. Study of BPH Drug (Business Wire)
10/20/08 11:10 am	Statins Reduce Risk of Alzheimer's Disease According to New Long-Term Prospective Study (Business Wire)
10/10/08 11:10 am	Nymox NX-1207 Successful Clinical Trial Results Featured in Urology Times (Business Wire)
10/08/08 10:10 am	Nymox Updates NX-1207 Product Development Activities (Business Wire)